Riskpilot← Back to searchSign inGet full accessHARSTAD OPTIKK AS
ASActiveOrg 992259442Storgata 2, 9405 HarstadRetail sale of medical and orthopaedic goods · NACE 4774Est. 200810 employees
Revenue 2025
NOK 20M
+1% vs 2024
EBITDA margin
7.2%
-51% vs 2024
Equity ratio
27.7%
Financial strength
Net profit 2025
NOK 796K
-59% vs 2024
| Revenue | NOK 20M | +1% |
| EBITDA | NOK 1,4M | -51% |
| Net profit | NOK 796K | -59% |
| Total assets | NOK 5,7M | -6% |
| Equity | NOK 1,6M | +97% |
| Employees | 10 | — |
Legal name
HARSTAD OPTIKK AS
Org number
992259442
Legal form
Aksjeselskap
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
31. januar 2008
Share capital
NOK 100 000
Employees
10 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Daglig leder eller styrets leder hver for seg.
Company purpose
Butikkhandel med ur, foto- og optiske artikler.
Address
Storgata 2, 9405 Harstad
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 17 880 | 17 743 | 18 966 | 19 836 | 20 026 |
| Staff expenses | −4 083 | −4 350 | −4 749 | −4 902 | −5 371 |
| EBITDA | 3 024 | 2 047 | 2 651 | 2 925 | 1 446 |
| Depreciation & amort. | −103 | −211 | −400 | −381 | −376 |
| EBIT | 2 921 | 1 836 | 2 251 | 2 544 | 1 070 |
| Net financials | 2 | −24 | −36 | −33 | −0 |
| Profit before tax | 2 922 | 1 812 | 2 215 | 2 511 | 1 070 |
| Tax | 639 | 339 | 501 | 576 | 275 |
| Net profit | 2 283 | 1 473 | 1 714 | 1 935 | 796 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 7 160 | 6 526 | 5 999 | 6 016 | 5 677 |
| Equity | 2 174 | 950 | 951 | 801 | 1 575 |
| Long-term debt | 0 | 613 | 470 | 318 | 0 |
| Short-term debt | 4 986 | 4 963 | 4 578 | 4 897 | 3 488 |
| Total debt | 4 986 | 5 576 | 5 048 | 5 215 | 4 103 |
EBITDA margin
7.2%
This company
15.8%
Market median
-54% vs market
20212025
Equity ratio
27.7%
This company
38.2%
Market median
-27% vs market
20212025
Return on equity
50.5%
This company
18.4%
Market median
+174% vs market
20212025
Net profit margin
4.0%
This company
8.1%
Market median
-51% vs market
20212025
Asset turnover
3.53×
This company
1.12×
Market median
+215% vs market
20212025
Debt / equity
2.61×
This company
0.62×
Market median
-321% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MH Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Walsen As
HARSTAD OPTIKK AS Board members of HARSTAD OPTIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marianne Hammer Walseth | Chief Executive Officer | 0 companies |
| Kenneth Mikalsen | Chairman | 0 companies |